Elevated Serum ALT Levels during Pegylated Interferon Monotherapy May Be Caused by Hepatic Iron Overload

Publisher： Karger

E-ISSN： 1423-0100|51|1|76-85

ISSN： 0300-5526

Source： Intervirology, Vol.51, Iss.1, 2008-06, pp. : 76-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Transaminase Elevations during Pegylated Interferon Treatment of Chronic HCV Hepatitis Probably Induced by Polyethylene Glycol

By  

Intervirology, Vol. 51, Iss. 6, 2009-03 ,pp. : 407-409

Karger

Access to resources Recommend Favorite

Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1542-1551

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relaxivity‐iron calibration in hepatic iron overload: Predictions of a Monte Carlo model

By  

MAGNETIC RESONANCE IN MEDICINE, Vol. 74, Iss. 3, 2015-09 ,pp. : 879-883

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1613-1620

John Wiley & Sons Inc

Access to resources Recommend Favorite